Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 5, 2003, Pages 856-861

  Oshitani, Nobuhide ^a   Hato, Fumihiko ^a   Kitagawa, Seiichi ^a   Watanabe, Kenji ^a   Fujiwara, Yasuhiro ^a   Higuchi, Kazuhide ^a   Matsumoto, Takayuki ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; MESALAZINE; PARASITE ANTIBODY; PARASITE ANTIGEN; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BEHCET DISEASE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SERUM; ULCERATIVE COLITIS;

ADULT; AGED; ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS; CAENORHABDITIS ELEGANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATORY BOWEL DISEASES; MALE; MESALAMINE; MIDDLE AGED; SULFASALAZINE;

EID: 0141675195     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.5.856-861.2003     Document Type: Article

References (30)

1. Bansi, D. S., K. A. Fleming, and R. W. Chapman. 1996. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. Gut 38:384-389.
2. Barclay, G. R., H. McKenzie, J. Pennington, D. Parratt, and C. R. Pennington. 1992. The effect of dietary yeast on the activity of stable chronic Crohn's disease. Scand. J. Gastroenterol. 27:196-200.
3. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-2202.
4. Bhan, A. K., E. Mizoguchi, R. N. Smith, and A. Mizoguchi. 2000. Spontaneous chronic colitis in TCR-α-mutant mice; an experimental model of human ulcerative colitis. Int. Rev. Immunol. 19:123-128.
5. Burke, D. A., and A. T. R. Axon. 1988. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. Br. Med. J. 297:102-104.
6. Cario, E., and D. K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68:7010-7017.
7. Darfeuille-Michaud, A., C. Neut, N. Barnich, E. Lederman, P. Di Martino, P. Desreumaux, L. Gambiez, and B. Joly. 1998. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115:1405-1413.
8. de Dombal, F. T., A. Softley, et al. 1987. IOIBD report no 1: observer variation in calculating indices of severity and activity in Crohn's disease. Gut 28:474-481.
9. Gulwani-Akolkar, B., P Akolkar, M. N. McKinley, S. E. Fisher, and J. Silver, J. 1995. Crohn's disease is accompanied by changes in the CD4+, but not CD8+, T cell receptor BV repertoire of lamina propria lymphocytes. Clin. Immunol. Immunopathol. 77:95-106.
10. Gulwani-Akolkar, B., P. N. Akolkar, A. Minassian, M. McKinley, S. Fisher, and J. Silver. 1996. CD4+ cell oligoclonality in Crohn's disease: evidence for an antigen-specific response. Hum. Immunol. 48:114-124.
11. Gulwani-Akolkar, B., P. N. Akolkar, A. Minassian, R. Pergolizzi, M. McKinley, G. Mullin, S. Fisher, and J. Silver. 1996. Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease. J. Clin. Investig. 98:1344-1354.
12. Inoue, N., K. Tamura, Y. Konouchi, Y. Fukuda, et al. 2002. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 123:86-91.
13. International Study Group for Behcet Disease. 1990. Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080.
14. Lawrance, I. C., C. Fiocchi, and S. Chakravarti. 2001. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum. Mol. Genet. 10:445-456.
15. Main, J., H. McKenzie, G. R. Yeaman, M. A. Kerr, D. Robson, C. R. Pennington, and D. Parratt. 1988. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. Br. Med. J. 297:1105-1106.
16. Ogawa, H., H. Ito, A. Takeda, S. Kanazawa, M. Yamamoto, H. Nakamura, Y. Kimura, K. Yoshizaki, and T. Kishimoto. 1997. Universal skew of T cell receptor (TCR) Vβ usage for Crohn's disease (CrD). Biochem. Biophys. Res. Commun. 240:545-551.
17. Ohara, M., T. Hibi, N. Watanabe, K. Kobayashi, H. Takaishi, A. Hayashi, Y. Hosoda, K. Toda, Y. Iwao, and M. Watanabe. 1995. Immunoglobulin G subclass distribution of human anticolon antibodies in ulcerative colitis. J. Gastroenterol. Hepatol. 10:158-164.
18. Oshitani, N., F. Hato, T. Matsumoto, Y. Jinno, Y. Sawa, J. Hara, S. Nakamura, S. Seki, T. Arakawa, A. Kitano, S. Kitagawa, and T. Kuroki. 2000. Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease. J. Gastroenterol. Hepatol. 15:1400-1403.
19. Oshitani, N., F. Hato, Y. Jinno, Y. Sawa, S. Nakamura, T. Matsumoto, S. Seki, T. Arakawa, and T. Kitagawa. 2001. IgG subclasses of anti-Saccharomyces cerevisiae antibody in inflammatory bowel disease. Eur. J. Clin. Investig. 31:221-225.
20. Oshitani, N., F. Hato, S. Kitagawa, K. Maeda, K. Higuchi, T. Matsumoto, and T. Arakawa. 2003. Analysis of intestinal HLA-DR abound peptides and dysregulated immune responses to enteric flora in the pathogenesis of inflammatory bowel disease. Int. J. Mol. Med. 11:99-104.
21. Sartor, R. B. 1997. Enteric microflora in IBD: pathogens of commensals? Inflamm. Bowel Dis. 3:230-235.
22. Schultz, C., M. Moussa, R. van Ketel, G. N. J. Tytgat, and J. Dankert. 1997. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J. Clin. Pathol. 50:573-579.
23. Schultz, M., S. L. Tonkonogy, R. K. Sellon, C. Veltkamp, V. L. Godfrey, J. Kwon, W. B. Grenther, E. Balish, I. Horak, and R. B. Sartor. 1999. IL-2-deficient mice raised under germ free conditions develop delayed mild focal intestinal inflammation. Am. J. Physiol. 276:G1461-G1472.
24. Seibold, F., K. Mork, S. Tanza, A. Muller, C. Holzhuter, P. Weber, and M. Sheurlen. 1997. Pancreatic autoantibodies in Crohn's disease: a family study. Gut 40:481-484.
25. Sellon, R., S. Tonkogony, M. Schultz, and R. B. Sartor. 1997. Absence of gastritis and colitis in germ-free IL-10 knockout mice. Gastroenterology 112:A1088.
26. Shur, P. H. 1987. IgG subclasses - a review. Ann. Allergy 58:89-96.
27. Tabaqchali, S, D. P. O'Donoghue, and K. A. Bettelheim. 1978. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 19:108-113.
28. van Heel, D. A., D. P. B. McGovern, and D. P. Jewell. 2001. Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357:1902-1904.
29. Wehkamp, J., K. Fellermann, K. R. Herringer, S. Baxmann, K. Schmidt, B. Schwind, M. Duchrow, C. Wohlshlager, A. C. Feller, and E. F. Stange. 2002. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 14:745-752.
30. Yamazaki, K., M. Takazoe, T. Tanaka, T. Kazumori, and Y. Nakamura. 2002. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J. Hum. Genet. 47:469-472.